The global consumer health market is shifting under inflation, supply chain pressures, and post-COVID demand changes, with digestive health and skin treatments showing resilience while cough and cold categories remain volatile. Regional performance diverges, with Western Europe and Latin America recovering in volume, while APAC and North America face muted demand and channel shifts. Growth opportunities lie in consumer-driven categories like probiotics and laxatives. Success requires leveraging consumer insights, optimizing e-commerce, innovating products, and collaborating with retailers and HCPs. Movicol’s OTC transition exemplifies how data, education, and partnerships can unlock sustained category growth.

Join for free to read